Healthy Extracts Inc (OTC: HYEX) is a nutritional supplement company that develops, manufactures, and distributes plant-based health products targeting heart health, cognitive function, and immune support. Revenue comes from transactional product sales across two primary lines: BergaMet citrus bergamot supplements and Fuel4Thought (F4T) brain-performance gel packs. The company operates in the highly competitive vitamins, minerals, herbs, and nutritional supplements industry, competing against other supplement manufacturers, distributors, and marketers both within and outside the U.S. (per 10-K filed 2026-04-09). BergaMet products, including BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART, are sold in tablet and capsule form. The F4T line uses patent-protected gel-pack delivery technology. The company is a smaller reporting company and emerging growth company. Kevin "Duke" Pitts serves as a signatory executive and Robert Madden as Chief Financial Officer, Secretary, and Principal Accounting Officer, as disclosed in the 10-K filed April 8, 2026.

Revenue model

Transactional product sales of nutritional supplements sold directly to consumers and through distribution partners. Customer purchases carry no contractual obligation to reorder. Marketing relies on social media, brand ambassadors, influencers, and celebrity spokespersons (per 10-K filed 2026-04-09).

Products and services

BergaMet line: BergaMet Pro+ (47% BPF Gold potency), BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART. All vegan-friendly, non-GMO, and gluten-free. Fuel4Thought (F4T) gel-pack line: Brain Activate Gel (without caffeine) and Brain Activate ENERGY Gel, using a patent-protected single-serving gel-pack delivery format with a formulation of C8 MCT, Neumentix, and Floragio (per 10-K filed 2026-04-09). The company also acquired Gummy USA LLC (per cash flow statement, FY2025).

Customers and end markets

Direct-to-consumer and distribution-partner channel. End markets include heart health, immune support, metabolic syndrome management, and cognitive performance. No customer concentration disclosures were provided in the filing excerpts.

Value-chain role

Product developer and brand owner that sources active ingredients from third-party suppliers, including H&AD and Brand Internationals/Analytical Resource Laboratory, and sells finished supplements under its own brands. Manufacturing and testing performed by certified U.S. facilities as represented by suppliers (per 10-K filed 2026-04-09).

Geographic exposure

Primarily U.S.-based operations. The filing references competition within and outside the U.S. but does not specify international revenue breakdown (per 10-K filed 2026-04-09).

Source: SEC 10-K, filed 2026-04-09

Industry: Medicinal Chemicals & Botanical Products